Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | CASI |
Description | NASDAQ: CASI | 中文 | Contact Us --> About Us Management Team Board of Directors Corporate Governance Contact Us Career Opportunities Pipeline CNCT19 BI- |
Keywords | N/A |
WebSite | casipharmaceuticals.com |
Host IP | 64.207.139.211 |
Location | United States |
Site | Rank |
US$21,523,661
Last updated: 2023-05-01 02:03:45
casipharmaceuticals.com has Semrush global rank of 491,752. casipharmaceuticals.com has an estimated worth of US$ 21,523,661, based on its estimated Ads revenue. casipharmaceuticals.com receives approximately 2,483,500 unique visitors each day. Its web server is located in United States, with IP address 64.207.139.211. According to SiteAdvisor, casipharmaceuticals.com is safe to visit. |
Purchase/Sale Value | US$21,523,661 |
Daily Ads Revenue | US$19,868 |
Monthly Ads Revenue | US$596,040 |
Yearly Ads Revenue | US$7,152,478 |
Daily Unique Visitors | 165,567 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
casipharmaceuticals.com. 1799 | A | casipharmaceuticals.com. 1799 | IP: 64.207.139.211 |
casipharmaceuticals.com. 1800 | NS | casipharmaceuticals.com. 1800 | NS Record: dns1.registrar-servers.com. |
casipharmaceuticals.com. 1800 | NS | casipharmaceuticals.com. 1800 | NS Record: dns2.registrar-servers.com. |
casipharmaceuticals.com. 3600 | MX | casipharmaceuticals.com. 3600 | MX Record: 0 casipharmaceuticals-com.mail.protection.outlook.com. |
casipharmaceuticals.com. 3600 | TXT | casipharmaceuticals.com. 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
casipharmaceuticals.com. 1799 | TXT | casipharmaceuticals.com. 1799 | TXT Record: MS=ms56818720 |
NASDAQ: CASI | 中文 | Contact Us --> About Us Management Team Board of Directors Corporate Governance Contact Us Career Opportunities Pipeline CNCT19 BI-1206 CB-5339 CID-103 Octreotide Thiotepa ZEVALIN® MARQIBO® Other Assets Partnering Clinical Trials Investor Center News Events Special Meeting Analyst Coverage SEC Filings --> CASI Menu About Us Management Team Board of Directors Corporate Governance Career Opportunities Product Pipeline BI-1206 CB-5339 CID-103 Octreotide Thiotepa Other Assets Partnering Clinical Trials Investor Center News Events Special Meeting Analyst Coverage SEC Filings Menu --> --> CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (EVOMELA ® ). Learn More Bringing life-changing therapeutics to China and the world. Learn More CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection (EVOMELA ® ). Learn More A biopharmaceutical company dedicated to bringing high quality, |
HTTP/1.1 301 Moved Permanently Date: Sat, 23 Oct 2021 17:50:31 GMT Server: Apache/2.4.39 Location: https://www.casipharmaceuticals.com/ Content-Type: text/html; charset=iso-8859-1 |
Domain Name: CASIPHARMACEUTICALS.COM Registry Domain ID: 1847333496_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.namecheap.com Registrar URL: http://www.namecheap.com Updated Date: 2020-01-20T16:17:48Z Creation Date: 2014-02-19T22:15:59Z Registry Expiry Date: 2022-02-19T22:15:59Z Registrar: NameCheap, Inc. Registrar IANA ID: 1068 Registrar Abuse Contact Email: abuse@namecheap.com Registrar Abuse Contact Phone: +1.6613102107 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.REGISTRAR-SERVERS.COM Name Server: DNS2.REGISTRAR-SERVERS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T03:54:12Z <<< |